Feasibility study of post-SBRT adjuvant chemotherapy with tegafur-uracil in patients with stage I non-small cell lung cancer
- Conditions
- Stage I Non small cell lung cancer
- Registration Number
- JPRN-jRCT1091220068
- Lead Sponsor
- Kinji Nishiyama
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- OTHER
- Sex
- All
- Target Recruitment
- 30
1. pathologically or cytologically proved non-small cell lung cancer
2. clinical stage I (T1>=2cm,T2=<4cm)
3. never received thoracic radiation therapy
4. PS 0-2
5. tumor size of >=2cm and =<4cm
6. Being pulmonary tumor
7. Older than 20 years old
8. principal organs have normal function
9. estimated survival more than 6 months
10. considered inoperable or refused operation
11. got informed consent
1. pulmonary fibrosis found on chest radiography
2. syncronous or metachronous cancer with disease free interval within 5 years
3. had a history of chemotherapy for NSCLC within 5 years
4. indicated progressive disease before administration of UFT
5. under pregnancy
6. had angina, cardiac infarction or heart failure within 3 months with poor control
7. having poor control DM
8. having some infection
9. have fever higher than 38 degrees
10. routine use of steroids
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method